Coherus BioSciences, Inc. (Nasdaq: CHRS) today announced that the Patent Trial and Appeal Board (“PTAB”) of the United States ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE